NCT04481321 Clinical and Molecular Study of Endometriosis and Adenomyosis
| NCT ID | NCT04481321 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Endometriosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,300 participants |
| Start Date | 2006-05 |
| Primary Completion | 2040-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,300 participants in total. It began in 2006-05 with a primary completion date of 2040-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.
Eligibility Criteria
Inclusion Criteria: * Women of age between - 18 and 42 years old. * In-service care for one of the pelvic pain and/or infertility, or for a pelvic mass. * Having a radiological diagnosis made by a referral practitioner and/or operated in the department Exclusion Criteria: * HIV-positive women, HBV and HCV * During pregnancy * Having a cancer diagnosis * Refusing to sign a consent.
Contact & Investigator
Louis Marcellin, MD, PhD
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT04481321 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 42 Years, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04481321 currently recruiting?
Yes, NCT04481321 is actively recruiting participants. Contact the research team at charles.chapron@aphp.fr for enrollment information.
Where is the NCT04481321 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT04481321 clinical trial?
NCT04481321 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Louis Marcellin, MD, PhD at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 5,300 participants.